Page last updated: 2024-08-23

mefloquine and Ambulation Disorders, Neurologic

mefloquine has been researched along with Ambulation Disorders, Neurologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaza, M; Ishihara, S; Kobayashi, Z; Mizusawa, H; Morio, T; Nakamichi, K; Numasawa, Y; Saijo, M; Sanjo, N; Shimizu, N; Shintani, S; Tomimitsu, H1

Other Studies

1 other study(ies) available for mefloquine and Ambulation Disorders, Neurologic

ArticleYear
Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.
    Journal of the neurological sciences, 2013, Jan-15, Volume: 324, Issue:1-2

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Apraxias; Asian People; Brain; DNA, Viral; Gait Disorders, Neurologic; Gene Dosage; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Mefloquine; Middle Aged; Muscle Cramp; Paresis; Rituximab; Treatment Failure

2013